{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T11:25:24Z","timestamp":1740137124695,"version":"3.37.3"},"reference-count":5,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer Inc.","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Taisho Toyama Pharmaceutical Co."},{"DOI":"10.13039\/100009954","name":"TAIHO Pharmaceutical Co.","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100009954","id-type":"DOI","asserted-by":"crossref"}]},{"name":"DAIICHI SANKYO CO"},{"name":"Meiji Seika Pharma Co."},{"name":"Sumitomo Dainippon Pharma Co."},{"name":"MSD"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.cmi.2017.11.013","type":"journal-article","created":{"date-parts":[[2017,11,23]],"date-time":"2017-11-23T15:31:28Z","timestamp":1511451088000},"page":"325","source":"Crossref","is-referenced-by-count":0,"title":["Comparison of antipseudomonal \u03b2-lactams for febrile neutropenia empiric therapy: authors' response"],"prefix":"10.1016","volume":"24","author":[{"given":"N.","family":"Horita","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Shibata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Namkoong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Kaneko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2017.11.013_bib1","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.cmi.2017.03.024","article-title":"Comparison of antipseudomonal \u03b2-lactams for febrile neutropenia empiric therapy: systematic review and network meta-analysis","volume":"23","author":"Horita","year":"2017","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2017.11.013_bib2","first-page":"e56","article-title":"Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America","volume":"52","author":"Infectious Diseases Society of America","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2017.11.013_bib3","doi-asserted-by":"crossref","first-page":"3387","DOI":"10.1093\/jac\/dku305","article-title":"A multicentre cohort study on colonization and infection with ESBL-producing Enterobacteriaceae in high-risk patients with haematological malignancies","volume":"69","author":"Vehreschild","year":"2014","journal-title":"Antimicrob Chemother"},{"issue":"14S3","key":"10.1016\/j.cmi.2017.11.013_bib4","doi-asserted-by":"crossref","first-page":"e171","DOI":"10.1016\/j.ijid.2010.01.004","article-title":"Cefepime-resistant Gram-negative bacteremia in febrile neutropenic patients with hematological malignancies","author":"Chong","year":"2010","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.cmi.2017.11.013_bib5","doi-asserted-by":"crossref","first-page":"ofx113","DOI":"10.1093\/ofid\/ofx113","article-title":"The dose-dependent efficacy of cefepime in the empiric management of febrile neutropenia: a systematic review and meta-analysis","volume":"4","author":"Andreatos","year":"2017","journal-title":"Open Forum Infect Dis"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X17306444?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X17306444?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,3,2]],"date-time":"2019-03-02T11:05:15Z","timestamp":1551524715000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X17306444"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":5,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["S1198743X17306444"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2017.11.013","relation":{},"ISSN":["1198-743X"],"issn-type":[{"type":"print","value":"1198-743X"}],"subject":[],"published":{"date-parts":[[2018,3]]}}}